Press release
Scleritis Market Set to Reach $5.54 Billion by 2029 with 8.9% Yearly Growth
Scleritis
The increasing prevalence of autoimmune diseases is expected to drive the growth of the scleritis market. Autoimmune diseases are conditions where the body's immune system mistakenly attacks healthy cells and tissues, thinking they are foreign invaders. The rise in autoimmune diseases is linked to genetic predispositions, environmental factors, lifestyle changes, and increased awareness, leading to better diagnosis. Autoimmune diseases cause scleritis by triggering an inflammatory immune response that attacks the scleral tissue, causing pain and redness. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, yielding a raw prevalence rate of 8.61%. Therefore, the rise in autoimmune diseases is driving the growth of the scleritis market.
Get Your Scleritis Market Report Here:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report
What growth opportunities are expected to drive the scleritis market's CAGR through 2034?
The scleritis market has expanded rapidly, increasing from $3.60 billion in 2024 to $3.94 billion in 2025 at a CAGR of 9.3%. This growth has been fueled by an increasing prevalence of autoimmune disorders, a rise in awareness of ocular health, an aging population, improved access to ophthalmic care, and advancements in global healthcare infrastructure.
The scleritis market is poised for strong growth, reaching $5.54 billion by 2029 at a CAGR of 8.9%. Growth drivers include an increasing incidence of eye-related health conditions, rising awareness of ocular health, higher healthcare expenditures, expanding ophthalmology research, and the demand for personalized treatments. Key industry trends include the development of targeted biologic therapies, advancements in immunosuppressive drug formulations, improvements in imaging technologies, adoption of minimally invasive diagnostic tools, increased focus on personalized medicine, advancements in drug delivery systems, and the application of AI in diagnostics and treatment planning.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
What are the emerging trends shaping the future of the scleritis market?
In the scleritis market, leading companies are focused on developing advanced products like eye drops to address inflammation and provide non-invasive treatment options. For example, in May 2023, Entod Pharmaceuticals launched CYCLOTEARS eye drops, which incorporate proprietary SEDDS technology to enhance drug delivery and efficacy. This novel therapy is designed to treat inflammatory eye diseases such as ocular myositis and scleritis, offering a significant advancement in eye inflammation treatment.
Which growth-oriented segments of the scleritis market are leading the industry's development?
The scleritis market covered in this report is segmented -
1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types
2) By Treatment: Medication, Surgery, Other Treatment
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21283
What regions are leading the charge in the scleritis market?
North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the scleritis market?
Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
What Is Covered In The Scleritis Global Market Report?
•Market Size Forecast: Examine the scleritis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the scleritis market for a structured understanding.
•Key Players Overview: Analyze major players in the scleritis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the scleritis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the scleritis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the scleritis market.
•Industry Challenges: Identify potential risks and obstacles affecting the scleritis market.
•Competitive Landscape: Review strategic developments in the scleritis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Scleritis Market Set to Reach $5.54 Billion by 2029 with 8.9% Yearly Growth here
News-ID: 3934709 • Views: …
More Releases from The Business Research Company
Comprehensive Insights Into The Global Electric Bikes And Scooters Market: Key G …
The electric bikes and scooters report outlines and analyzes the electric bikes and scooters (excluding e-mopeds or 2-wheelers) market, covering the historic period 2019-2024 and the forecast period 2024-2029 and 2034F. The study examines the market across all regions and major regional economies.
The global electric bikes and scooters (excluding e-mopeds or 2 wheelers) market was valued at approximately $43.09310 billion in 2024, reflecting a CAGR of 12.12% since 2019. The…
Geothermal Heat Pump Market Report 2025: Size, Trends, and Key Growth Insights f …
The geothermal heat pump report outlines and analyzes the geothermal heat pump market, covering 2019-2024 as the historic period and 2024-2029, 2034F as the forecast period. The report examines the market across every region and assesses major economies within each region.
The global geothermal heat pump market reached $4.40620 billion in 2024, increasing at a CAGR of 5.70% since 2019. The market is projected to grow from $4.40620 billion in 2024…
Major Growth Driver Identified in 2025 VFX In Advertising Market: The Rise Of So …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
VFX In Advertising Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past several years, the market size of vfx in advertising has seen robust growth. It is expected to expand from $2.8 billion in 2024 to a staggering $3.03 billion in 2025, exhibiting…
Driving Web Content, Search Portals And Social Media Market Growth in 2025: The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Web Content, Search Portals And Social Media Market Size Growth Forecast: What to Expect by 2025?
The market size for web content, search portals, and social media has seen quick expansion in the past few years. It's projected to expand from $682.14 billion in 2024 to $768.29 billion in…
More Releases for Scleritis
Global Scleritis Market Expected to Achieve 8.7% CAGR by 2029: Growth Forecast I …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Scleritis Market Size By 2025?
The overall valuation of the scleritis market has seen robust expansion lately, projected to climb from its 2024 standing of $3.6 billion to reach $3.93 billion by 2025, reflecting a 9.0% compound annual growth rate during this interval. This…
Scleritis Market: Biologic Advances and Early Diagnosis Drive Growth to 2034
Subheadline:
Growing autoimmune disease awareness, biologic drug adoption, and precision ophthalmology tools are driving steady growth in the global scleritis treatment market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72281
Introduction
The Scleritis Market is witnessing gradual but significant growth as advances in biologic drugs, early autoimmune diagnostics, and ocular immunology research reshape disease management strategies.
Valued at USD 270 million in 2024, the market is projected to reach USD 490 million by…
Scleritis Market to Reach USD 2.2 Billion by 2034
Scleritis is a serious inflammatory disease of the sclera, the white outer coating of the eye. It is often associated with systemic autoimmune conditions such as rheumatoid arthritis, granulomatosis with polyangiitis, lupus, and inflammatory bowel disease. Symptoms include severe ocular pain, redness, and potential vision loss if untreated.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72281
Unlike episcleritis, scleritis is more severe and frequently requires systemic immunosuppressive therapy or biologics.…
Strong Growth Ahead: Scleritis Market Size To Grow At Arecord 8.9% Cagr By 2029
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Scleritis Market Size Expected to Be by 2034?
The market for scleritis has seen significant growth in the past few years. The market, which was worth $3.60 billion in 2024, is expected to reach a value of $3.94 billion in 2025, growing at a compound annual growth rate…
Scleritis Market Business Opportunities And Regional Outlook 2022-28
According to Precision Business Insights (PBI), latest report, the scleritis market is expected to have a CAGR of 5.8% during the forecast period 2022 to 2028. The primary drivers of the expansion of the global scleritis market include the increasing prevalence of scleritis, the growing geriatric population, developing healthcare infrastructure in economic countries, and technological advancements in treatment and diagnosis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/scleritis-market/ …
Healthcare Scleritis Market : Technological Breakthroughs, Value Chain And Stake …
Scleritis Market Information, by Types (Diffuse Anterior Scleritis, Nodular Anterior Scleritis, Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis, Posterior Scleritis) by treatment types (Non-Steroidal Anti-Inflammatory Drugs, Oral Glucocorticoids, Immunosuppressive Drugs) - Forecast to 2022
Study objectives of the Market:
• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Scleritis market
• To provide insights about factors affecting the market growth
• To…
